TTRX Turn Therapeutics Inc. - Common Stock
$4.64
Price · May 20, 2026
Fundamentals as of May 11, 2026
52W Range
$3–$26
9% of range
Analyst Rating
BUY
8 analysts
Price Target
$8
+72% upside
P/E (TTM)
-32.8
ROE
-141.7%
Net Profit Margin
—
TTRX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$4.64
Market Cap
$116M
P/E (TTM)
-32.8
EPS (TTM)
$-0.12
Revenue (TTM)
—
Div Yield
—
ROE
-141.7%
Debt/Equity
—
52W Range
$3 – $27
TTRX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
$-0.12
2024-12-31
→
2025-12-31
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
TTRX
Peer Median
P/E (TTM)
-32.8
22.6
P/B
24.8
2.7
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
TTRX
Peer Median
ROA
-45.0%
-48.6%
ROE
-141.7%
-59.0%
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
TTRX
Peer Median
Current Ratio
0.9
1.7
Quick Ratio
0.7
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
TTRX
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
TTRX
Peer Median
TTRX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
8 analysts
- Strong Buy 2 25.0%
- Buy 5 62.5%
- Hold 1 12.5%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
1 analysts · 2026-05-15
Low
$8.00
High
$8.00
Median target
$8.00
+72.4%
Mean target
$8.00
+72.4%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.00%
Next Report
Jun 25, 2026
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.03 | $-0.03 | -0.00% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| TTRX | $116M | -32.8 | — | — | -141.7% | — |
| DERM | — | -16.4 | 10.2% | -18.5% | -44.7% | — |
| ANTX | $31M | -1.0 | — | — | -57.7% | — |
| PLYX | — | — | — | — | -193.7% | — |
| ASRT | $58M | -1.9 | -5.0% | -25.6% | -32.4% | — |
| NTHI | — | -2.6 | -51.8% | — | — | — |
| RANI | — | -3.0 | 58.9% | -1817.1% | -169.6% | — |
| CGTX | $120M | -4.2 | — | — | -113.7% | — |
| NRXP | — | — | — | — | — | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 12
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| R&D Expense | $265.6K | $246.0K | |
| SG&A Expense | $6M | $2M | |
| Operating Expenses | $6M | $2M | |
| Operating Income | $-6M | $-2M | |
| Interest Income | $29.6K | $28.7K | |
| Other Non-op | $176.5K | · | |
| Net Income | $-3M | $-2M | |
| EPS (Basic) | $-0.12 | $-0.07 | |
| EPS (Diluted) | $-0.12 | $-0.07 | |
| Shares (Basic) | 27,716,045 | 26,643,432 | |
| Shares (Diluted) | 27,716,045 | 26,643,432 | |
| EBITDA | $-6M | · |
Balance Sheet 13
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $4M | $498.3K | |
| Prepaid Expense | $120.3K | $225.3K | |
| Current Assets | $5M | $1M | |
| Intangibles | $922.2K | $821.9K | |
| Total Assets | $12M | $2M | |
| Current Liabilities | $6M | $707.9K | |
| Capital Leases | $34.1K | $80.4K | |
| Total Liabilities | $7M | $2M | |
| Common Stock | $2.9K | $2.7K | |
| Retained Earnings | $-22M | $-19M | |
| Stockholders' Equity | $5M | $-177.4K | |
| Liabilities + Equity | $12M | $2M | |
| Shares Outstanding | 29,445,183 | 26,845,690 |
Cash Flow 8
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| D&A | $52.7K | $47.5K | |
| Stock-based Comp | $419.2K | $352.8K | |
| Amort. of Intangibles | $53.0K | $47.0K | |
| Operating Cash Flow | $-3M | $-1M | |
| Investing Cash Flow | $-153.0K | $-99.5K | |
| Stock Issued | $7M | $1M | |
| Net Stock Activity | $7M | · | |
| Financing Cash Flow | $7M | $1M |
Profitability 2
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| ROA | -45.0% | · | |
| ROE | -141.7% | · |
Liquidity & Solvency 2
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 0.9 | · | |
| Quick Ratio | 0.7 | · |
Valuation (TTM) 7
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Net Income TTM | $-3M | · | |
| Market Cap | $116M | · | |
| P/E | -32.8 | · | |
| P/B | 24.8 | · | |
| P / Tangible Book | 30.8 | · | |
| P / Cash Flow | -45.3 | · | |
| Earnings Yield | -3.0% | · |
Income Statement 12
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q4 2024 |
|---|---|---|---|---|---|
| R&D Expense | $109.4K | $34.9K | $158.7K | $9.8K | |
| SG&A Expense | $1M | $2M | $2M | $319.2K | |
| Operating Expenses | $1M | $2M | $2M | $329.0K | |
| Operating Income | $-1M | $-2M | $-2M | $-329.0K | |
| Interest Income | $49.7K | $14.2K | $5.1K | $5.8K | |
| Other Non-op | $5.6K | $0 | $4.3K | · | |
| Net Income | $-971.0K | $279.1K | $-2M | $-323.1K | |
| EPS (Basic) | $-0.03 | $0.01 | $-0.07 | $-0.02 | |
| EPS (Diluted) | $-0.03 | $0.01 | $-0.07 | $-0.02 | |
| Shares (Basic) | 29,476,002 | 236,799 | 27,975,207 | 96,592 | |
| Shares (Diluted) | 29,476,002 | 236,799 | 27,975,207 | 96,592 | |
| EBITDA | $-1M | · | $-2M | · |
Balance Sheet 15
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q4 2024 |
|---|---|---|---|---|---|
| Cash & Equivalents | $11M | $4M | $513.7K | $498.3K | |
| Prepaid Expense | $235.2K | $120.3K | $188.6K | $225.3K | |
| Current Assets | $11M | $5M | $3M | $1M | |
| Intangibles | $919.9K | $922.2K | $904.9K | $821.9K | |
| Total Assets | $19M | $12M | $4M | $2M | |
| Current Liabilities | $5M | $6M | $2M | $707.9K | |
| Capital Leases | $21.5K | $34.1K | $46.3K | $80.4K | |
| Total Liabilities | $13M | $7M | $4M | $2M | |
| Long-term Debt | $7M | · | · | · | |
| Total Debt | $6M | · | · | · | |
| Common Stock | $3.0K | $2.9K | $2.8K | $2.7K | |
| Retained Earnings | $-23M | $-22M | $-23M | $-19M | |
| Stockholders' Equity | $6M | $5M | $504.0K | $-177.4K | |
| Liabilities + Equity | $19M | $12M | $4M | $2M | |
| Shares Outstanding | 29,788,040 | 29,445,183 | 28,022,826 | 26,845,690 |
Cash Flow 5
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q4 2024 |
|---|---|---|---|---|---|
| Stock-based Comp | $280.8K | $256.4K | · | $37.8K | |
| Operating Cash Flow | $-2M | $-1M | · | $-430.5K | |
| Investing Cash Flow | $-12.2K | $-31.4K | · | $-7.8K | |
| Stock Issued | · | $3M | · | $522.2K | |
| Financing Cash Flow | $8M | $3M | · | $522.2K |
Profitability 2
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q4 2024 |
|---|---|---|---|---|---|
| ROA | -10.4% | · | -88.6% | · | |
| ROE | -31.7% | · | -755.6% | · |
Liquidity & Solvency 4
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q4 2024 |
|---|---|---|---|---|---|
| Current Ratio | 2.2 | · | 1.4 | · | |
| Quick Ratio | 2.1 | · | 0.2 | · | |
| Debt / Equity | 1.0 | · | · | · | |
| LT Debt / Equity | 1.0 | · | · | · |
Valuation (TTM) 6
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q4 2024 |
|---|---|---|---|---|---|
| Market Cap | $95M | · | · | · | |
| Enterprise Value | $90M | · | · | · | |
| P/B | 15.6 | · | · | · | |
| P / Tangible Book | 18.3 | · | · | · | |
| P / Cash Flow | -58.4 | · | · | · | |
| EV / EBITDA | -72.4 | · | · | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Net Income | $-3M | $-2M |
| Diluted EPS | $-0.12 | $-0.07 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Current Ratio | 0.9 | — |
| Quick Ratio | 0.7 | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.